Company page

Parabilis Medicines, Inc.

Parabilis Medicines, Inc. is a public company traded under the ticker PBLS in the American market. With a market capitalization of approximately $3.49 billion, the company is focused on advancing its innovative therapies. Parabilis is dedicated to improving patient outcomes through its research and development efforts in the biopharmaceutical sector.